Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Hester A. De Groot-Kruseman"'
Autor:
Kirsten A. Thus, Hester A. de Groot-Kruseman, Pauline Winkler-Seinstra, Marta Fiocco, Heidi Segers, Cor van den Bos, Inge M. van der Sluis, Wim J.E. Tissing, Margreet A. Veening, Christian Michel Zwaan, Cornelis M. van Tilburg, Rob Pieters, Marc Bierings
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Infections lead to substantial morbidity during treatment of acute lymphoblastic leukemia (ALL) in which the adaptive immune system gets severely affected, leading to declining serum immunoglobulin levels. The aim of this trial was to investigate whe
Externí odkaz:
https://doaj.org/article/634bb1c123c8458d9d413f68bd657421
Autor:
Emma Kroeze, Dilys D. Weijers, Melanie M. Hagleitner, Hester A. de Groot-Kruseman, Marjolijn C. J. Jongmans, Roland P. Kuiper, Rob Pieters, Jules P. P. Meijerink, Jan L. C. Loeffen
Publikováno v:
HemaSphere, Vol 6, Iss 1, p e668 (2022)
This study describes the clinical characteristics of a complete Dutch T-cell lymphoblastic lymphoma (T-LBL) cohort, including second primary malignancies and comorbidities. We show that over 10% of patients in this complete T-LBL cohort have been dia
Externí odkaz:
https://doaj.org/article/edb66bd8c25f4a0b9bc5d4598177b458
Autor:
Jenneke E. van Atteveld, Hester A. de Groot-Kruseman, Marta Fiocco, Maarten H. Lequin, Sebastian J.C.M.M. Neggers, Saskia M.F. Pluijm, Inge M. van der Sluis, Rob Pieters, Marry M. van den Heuvel-Eibrink
Publikováno v:
Haematologica, Vol 106, Iss 4 (2020)
Externí odkaz:
https://doaj.org/article/d77a13f41783430aa103308987039b27
Autor:
Marissa A.H. den Hoed, Saskia M.F. Pluijm, Mariël L. te Winkel, Hester A. de Groot-Kruseman, Martha Fiocco, Peter Hoogerbrugge, Jan A. Leeuw, Marrie C.A. Bruin, Inge M. van der Sluis, Dorien Bresters, Maarten H. Lequin, Jan C. Roos, Anjo J.P. Veerman, Rob Pieters, Marry M. van den Heuvel-Eibrink
Publikováno v:
Haematologica, Vol 100, Iss 12 (2015)
Osteonecrosis and decline of bone density are serious side effects during and after treatment of childhood acute lymphoblastic leukemia. It is unknown whether osteonecrosis and low bone density occur together in the same patients, or whether these tw
Externí odkaz:
https://doaj.org/article/04cf8eba363d49d7844a32827a5c96ab
Autor:
Marissa A.H. den Hoed, Saskia M.F. Pluijm, Hester A. de Groot-Kruseman, Mariël L. te Winkel, Martha Fiocco, Erica L.T. van den Akker, Peter Hoogerbrugge, Henk van den Berg, Jan A. Leeuw, Marrie C.A. Bruin, Dorine Bresters, Anjo J.P. Veerman, Rob Pieters, Marry M. van den Heuvel-Eibrink
Publikováno v:
Haematologica, Vol 100, Iss 1 (2015)
Body mass index and change in body mass index during treatment may influence treatment outcome of pediatric patients with acute lymphoblastic leukemia. However, previous studies in pediatric acute lymphoblastic leukemia reported contradictory results
Externí odkaz:
https://doaj.org/article/7fed7e61aebe44419ec97dd76e7565aa
Autor:
Wing H. Tong, Rob Pieters, Hester A. de Groot-Kruseman, Wim C. J. Hop, Joachim Boos, Wim J. E. Tissing, Inge M. van der Sluis
Publikováno v:
Haematologica, Vol 99, Iss 11 (2014)
We prospectively studied the incidence and clinical course of hypertriglyceridemia and hypercholesterolemia during very prolonged use of asparaginase in relation to levels of asparaginase activity in children with acute lymphoblastic leukemia. We als
Externí odkaz:
https://doaj.org/article/d508af4794c249619ba71d7f1bde3ddd
Autor:
Romy E. van Weelderen, Kim Klein, Christine J. Harrison, Yilin Jiang, Jonas Abrahamsson, Nira Arad-Cohen, Emmanuelle Bart-Delabesse, Barbara Buldini, Barbara De Moerloose, Michael N. Dworzak, Sarah Elitzur, José M. Fernández Navarro, Robert B. Gerbing, Bianca F. Goemans, Hester A. de Groot-Kruseman, Erin Guest, Shau-Yin Ha, Henrik Hasle, Charikleia Kelaidi, Hélène Lapillonne, Guy Leverger, Franco Locatelli, Riccardo Masetti, Takako Miyamura, Ulrika Norén-Nyström, Sophia Polychronopoulou, Mareike Rasche, Jeffrey E. Rubnitz, Jan Stary, Anne Tierens, Daisuke Tomizawa, C. Michel Zwaan, Gertjan J.L. Kaspers
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(16), 2963-2974. American Society of Clinical Oncology
van Weelderen, R E, Klein, K, Harrison, C J, Jiang, Y, Abrahamsson, J, Arad-Cohen, N, Bart-Delabesse, E, Buldini, B, de Moerloose, B, Dworzak, M N, Elitzur, S, Fernández Navarro, J M, Gerbing, R B, Goemans, B F, de Groot-Kruseman, H A, Guest, E, Ha, S-Y, Hasle, H, Kelaidi, C, Lapillonne, H L, Leverger, G, Locatelli, F, Masetti, R, Miyamura, T, Norén-Nyström, U, Polychronopoulou, S, Rasche, M, Rubnitz, J E, Stary, J, Tierens, A, Tomizawa, D, Zwaan, C M & Kaspers, G J L 2023, ' Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia : A Study by the International Berlin-Frankfurt-Münster Study Group ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 41, no. 16, pp. 2963-2974 . https://doi.org/10.1200/JCO.22.02120
JOURNAL OF CLINICAL ONCOLOGY
van Weelderen, R E, Klein, K, Harrison, C J, Jiang, Y, Abrahamsson, J, Arad-Cohen, N, Bart-Delabesse, E, Buldini, B, de Moerloose, B, Dworzak, M N, Elitzur, S, Fernández Navarro, J M, Gerbing, R B, Goemans, B F, de Groot-Kruseman, H A, Guest, E, Ha, S-Y, Hasle, H, Kelaidi, C, Lapillonne, H L, Leverger, G, Locatelli, F, Masetti, R, Miyamura, T, Norén-Nyström, U, Polychronopoulou, S, Rasche, M, Rubnitz, J E, Stary, J, Tierens, A, Tomizawa, D, Zwaan, C M & Kaspers, G J L 2023, ' Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia : A Study by the International Berlin-Frankfurt-Münster Study Group ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 41, no. 16, pp. 2963-2974 . https://doi.org/10.1200/JCO.22.02120
JOURNAL OF CLINICAL ONCOLOGY
PURPOSE A previous study by the International Berlin-Frankfurt-Münster Study Group (I-BFM-SG) on childhood KMT2A-rearranged ( KMT2A-r) AML demonstrated the prognostic value of the fusion partner. This I-BFM-SG study investigated the value of flow cy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cccda2bbe5c51ff6074f87e156c5eb4a
http://www.scopus.com/inward/record.url?scp=85160455151&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85160455151&partnerID=8YFLogxK
Autor:
Ruben van Boxtel, Bianca F. Goemans, C. Michel Zwaan, Hester A. de Groot-Kruseman, Markus J. van Roosmalen, Rurika Oka, Marry M. van den Heuvel-Eibrink, Mark Verheul, Anaïs J.C.N. van Leeuwen, Arianne M. Brandsma, Jurrian K. de Kanter, Axel K.M. Rosendahl Huber, Eline J.M. Bertrums
Childhood cancer survivors are confronted with various chronic health conditions like therapy-related malignancies. However, it is unclear how exposure to chemotherapy contributes to the mutation burden and clonal composition of healthy tissues early
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f08e9ef66548e287e4204011bb36a9a
https://doi.org/10.1158/2159-8290.c.6549550
https://doi.org/10.1158/2159-8290.c.6549550
Autor:
Ruben van Boxtel, Bianca F. Goemans, C. Michel Zwaan, Hester A. de Groot-Kruseman, Markus J. van Roosmalen, Rurika Oka, Marry M. van den Heuvel-Eibrink, Mark Verheul, Anaïs J.C.N. van Leeuwen, Arianne M. Brandsma, Jurrian K. de Kanter, Axel K.M. Rosendahl Huber, Eline J.M. Bertrums
Supplementary Figure from Elevated Mutational Age in Blood of Children Treated for Cancer Contributes to Therapy-Related Myeloid Neoplasms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74f5187b9b26fb7ee257c2d7ae4cc5a5
https://doi.org/10.1158/2159-8290.22541080
https://doi.org/10.1158/2159-8290.22541080
Autor:
Joost B. Koedijk, Inge van der Werf, Marijn A. Vermeulen, Alicia Perzolli, Marta Fiocco, Hester A. de Groot-Kruseman, Rubina Moeniralam, Stefan Nierkens, Mirjam E. Belderbos, C. Michel Zwaan, Olaf Heidenreich
Pediatric cancers are characterized by a relatively low mutational burden and therefore, children are thought to be poor candidates for T cell-engaging immunotherapies. Here, we performed a multidimensional characterization of the tumor immune microe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc67c90206be9a5cd7841f3a964695f6
https://doi.org/10.1101/2023.03.03.23286485
https://doi.org/10.1101/2023.03.03.23286485